National Medical Care Co.’s (Care) CEO Abdulaziz Alobaid
National Medical Care Co.’s (Care) CEO Abdulaziz Al-Obaid attributed the Q4 2025 profit decline to the reversal of non-recurring legal provisions worth SAR 42 million that had been recognized in the same period a year earlier. 
In an interview with Argaam, the top executive added that, excluding the impact of these provisions, financial results show strong net profit growth of 71% year-on-year in Q4 2025.
He noted that revenue rose by 8.6% YoY to reach SAR 404.8 million in Q4 2025, driven by a 15% rise in patient visits for the same period.
Furthermore, Al-Salam Medical Hospital, which the company acquired in Q4 2024, currently contributes about 8% of Care’s total revenue, said the CEO, emphasizing that the company continues to implement its expansion strategy through acquisitions that align with its business model while creating shareholder value.
Al-Obaid also stated that Care adopts a diversified payer mix model, ensuring multiple revenue sources, with the General Organization for Social Insurance (GOSI) contributing around 35% to 40% of revenues, the Ministry of Health accounting for about 30-35%, insurance companies generating about 25%, and the remainder coming from corporates and cash-pay patients.
On the competitive front, Al-Obaid highlighted that Care holds a leading position as a key healthcare provider for the fast-growing tier-B segment, which represents the largest insured population in its core markets.
The increase in patient visits also significantly supported revenues, said the CEO, noting that the current occupancy rate stands at around 80%, reflecting the company’s aptitude to achieve further growth in the future.
The company’s management is focused on enhancing operational efficiency and reducing the average length of hospital stay, thus enabling serving more patients within existing capacity and sustain growth, Al-Obaid added.
He also emphasized Care’s long-term objective to maintain strong profit margins while maintaining operational expansion, with a strategic focus on sustaining profitability alongside growth.
According to Argaam’s data, Care’s net profit rose to SAR 318.5 million by the end of 2025, compared to SAR 294.7 million in 2024. Meanwhile, the Q4 2025 net profit reached SAR 71 million.
National Medical Care Co.’s (Care) CEO Abdulaziz Alobaid
National Medical Care Co.’s (Care) CEO Abdulaziz Al-Obaid attributed the Q4 2025 profit decline to the reversal of non-recurring legal provisions worth SAR 42 million that had been recognized in the same period a year earlier.
In an interview with Argaam, the top executive added that, excluding the impact of these provisions, financial results show strong net profit growth of 71% year-on-year in Q4 2025.
He noted that revenue rose by 8.6% YoY to reach SAR 404.8 million in Q4 2025, driven by a 15% rise in patient visits for the same period.
Furthermore, Al-Salam Medical Hospital, which the company acquired in Q4 2024, currently contributes about 8% of Care’s total revenue, said the CEO, emphasizing that the company continues to implement its expansion strategy through acquisitions that align with its business model while creating shareholder value.
Al-Obaid also stated that Care adopts a diversified payer mix model, ensuring multiple revenue sources, with the General Organization for Social Insurance (GOSI) contributing around 35% to 40% of revenues, the Ministry of Health accounting for about 30-35%, insurance companies generating about 25%, and the remainder coming from corporates and cash-pay patients.
On the competitive front, Al-Obaid highlighted that Care holds a leading position as a key healthcare provider for the fast-growing tier-B segment, which represents the largest insured population in its core markets.
The increase in patient visits also significantly supported revenues, said the CEO, noting that the current occupancy rate stands at around 80%, reflecting the company’s aptitude to achieve further growth in the future.
The company’s management is focused on enhancing operational efficiency and reducing the average length of hospital stay, thus enabling serving more patients within existing capacity and sustain growth, Al-Obaid added.
He also emphasized Care’s long-term objective to maintain strong profit margins while maintaining operational expansion, with a strategic focus on sustaining profitability alongside growth.
According to Argaam’s data, Care’s net profit rose to SAR 318.5 million by the end of 2025, compared to SAR 294.7 million in 2024. Meanwhile, the Q4 2025 net profit reached SAR 71 million.
